Marousa Kouvela
Overview
Explore the profile of Marousa Kouvela including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
22
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Eleftheriadou E, Saroglou M, Syrigos N, Kotteas E, Kouvela M
Monaldi Arch Chest Dis
. 2024 Jul;
PMID: 39077863
Worldwide, approximately half of the patients diagnosed with lung cancer (LC) will develop, simultaneously or asynchronously, brain metastases (BMs). The existence of BMs negatively affects the quality of life and...
2.
Kouvela M, Livanou M, Stefanou D, Vathiotis I, Sarropoulou F, Grammoustianou M, et al.
Cancers (Basel)
. 2024 Apr;
16(7).
PMID: 38611118
Background: The aim of this study was to record and assess the efficacy and safety ofthromboprophylaxis with an intermediate dose of Tinzaparin in lung cancer patients with high thrombotic risk....
3.
Stefanou D, Kouvela M, Stellas D, Voutetakis K, Papadodima O, Syrigos K, et al.
Biomedicines
. 2022 Jun;
10(6).
PMID: 35740268
The deregulated DNA damage response (DDR) network is associated with the onset and progression of cancer. Herein, we searched for DDR defects in peripheral blood mononuclear cells (PBMCs) from lung...
4.
Papaioannou A, Loukides S, Bakakos P, Kosmas E, Rovina N, Steiropoulos P, et al.
Int J Chron Obstruct Pulmon Dis
. 2020 Nov;
15:2695-2705.
PMID: 33149567
Pharmacological medications used for the treatment of COPD patients have increased significantly. Long-acting bronchodilators have been recognized as the mainstay of the treatment of stable COPD, while ICS are usually...
5.
Georgakopoulos P, Kyriakidis M, Perpinia A, Karavidas A, Zimeras S, Mamalis N, et al.
Anticancer Res
. 2019 Oct;
39(10):5703-5707.
PMID: 31570470
Background/aim: Anthracyclines, such as doxorubicin, though widely used in anticancer therapy, they are associated with cardiotoxic side-effects. The aim of this trial was to investigate long-term follow-up cardiotoxicity findings in...
6.
Kakavas S, Balis E, Lazarou V, Kouvela M, Tatsis G
Heart Lung
. 2013 Aug;
42(6):480-2.
PMID: 23969008
Although poorly understood, interstitial lung disease has been reported as a possible complication of tumor necrosis factor alpha inhibitors. We report a case of interstitial lung disease in a 64-year-old...